本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

SpringWorks Therapeutics, Inc.

41.21
+0.71001.75%
盘后49.047.83+19.00%17:21 EDT
成交量:191.12万
成交额:7,872.48万
市值:30.90亿
市盈率:-11.84
高:42.15
开:41.65
低:40.34
收:40.50
数据加载中...

公司资料

公司名字:
SpringWorks Therapeutics, Inc.
交易所:
NASDAQ
成立时间:
2017
员工人数:
368
公司地址:
100 Washington Boulevard,Stamford,Connecticut,United States
邮编:
06902
电话:
传真:
- -
简介:
SpringWorks Therapeutics, Inc.于2017年8月在特拉华州成立。该公司是一家临床阶段的生物制药公司,使用精密医学来为患有严重疾病和癌症的服务不足的患者人群获取,开发和商品化改变生命的药物。

董事

名称
职位
Daniel S. Lynch
Chairman of the Board
Saqib Islam
Chief Executive Officer and Director
Stephen Squinto
Director and Acting Head of Research and Development
Alan Fuhrman
Director
Carl L. Gordon
Director
Deval L. Patrick
Director
Freda Lewis Hall
Director
Jeffrey Schwartz
Director

股东

名称
职位
Saqib Islam
Chief Executive Officer and Director
Francis I. Perier, Jr.
Chief Financial Officer
L. Mary Smith
Senior Vice President, Clinical Research and Development
Badreddin Edris
Chief Business Officer
Jens Renstrup
Chief Medical Officer
Michael V. Greco
General Counsel and Secretary
Stephen Squinto
Director and Acting Head of Research and Development